Dr. Agarwal's Health Care Limited Stock Price Today (NSE: AGARWALEYE)
Fundamental Score
Dr. Agarwal's Health Care Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dr. Agarwal's Health Care Limited share price today is ₹468.55, up +0.87% on NSE/BSE as of 22 October 2026. Dr. Agarwal's Health Care Limited (AGARWALEYE) is a Mid-cap company in the Hospital sector with a market capitalisation of ₹14.85K (Cr). The 52-week high for AGARWALEYE share price is ₹567.75 and the 52-week low is ₹401.00. At a P/E ratio of 99.90x, AGARWALEYE is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 6.84% and a debt-to-equity ratio of 0.08.
Dr. Agarwal's Health Care Limited Share Price Chart — NSE/BSE Historical Performance
Dr. Agarwal's Health Care Limited share price chart: -7.76% return over the past month. 52-week high ₹567.75, 52-week low ₹401.00.
Dr. Agarwal's Health Care Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹468.25 | ₹468.25 | ₹454.20 | ₹464.50 | 1.20L (Cr) | |
| ₹466.95 | ₹469.50 | ₹462.70 | ₹468.30 | 84.55K (Cr) | |
| ₹479.55 | ₹479.70 | ₹463.20 | ₹465.80 | 1.43L (Cr) | |
| ₹469.00 | ₹491.15 | ₹463.35 | ₹477.15 | 3.93L (Cr) | |
| ₹474.25 | ₹475.10 | ₹463.45 | ₹467.90 | 2.12L (Cr) | |
| ₹476.75 | ₹476.75 | ₹466.65 | ₹471.35 | 1.45L (Cr) | |
| ₹473.55 | ₹480.95 | ₹471.00 | ₹475.20 | 1.20L (Cr) | |
| ₹470.00 | ₹482.50 | ₹459.15 | ₹477.75 | 2.45L (Cr) | |
| ₹485.10 | ₹485.15 | ₹465.35 | ₹471.00 | 2.09L (Cr) | |
| ₹480.25 | ₹490.00 | ₹479.10 | ₹483.25 | 2.00L (Cr) |
Dr. Agarwal's Health Care Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹472.70 | ₹492.05 | ₹454.20 | ₹464.50 | -1.73% | |
| ₹513.75 | ₹528.80 | ₹472.50 | ₹479.30 | -6.71% | |
| ₹477.90 | ₹567.75 | ₹477.35 | ₹513.20 | +7.39% | |
| ₹479.95 | ₹505.00 | ₹463.00 | ₹478.00 | -0.41% | |
| ₹489.00 | ₹492.25 | ₹437.00 | ₹478.95 | -2.06% | |
| ₹445.10 | ₹496.45 | ₹437.00 | ₹484.10 | +8.76% | |
| ₹412.60 | ₹469.75 | ₹407.70 | ₹445.10 | +7.88% | |
| ₹421.00 | ₹455.15 | ₹401.00 | ₹406.55 | -3.43% | |
| ₹443.05 | ₹462.70 | ₹431.00 | ₹451.70 | +1.95% | |
| ₹508.35 | ₹526.80 | ₹412.25 | ₹432.75 | -14.87% | |
| ₹531.80 | ₹541.25 | ₹478.00 | ₹508.35 | -4.41% | |
| ₹510.25 | ₹555.50 | ₹485.00 | ₹533.75 | +4.61% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dr. Agarwal's Health Care Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dr. Agarwal's Health Care Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AGARWALEYE across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Operating Margins (29.23%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (50.52%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (25.97%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (34.58% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (34.42% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹393.19 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 65.69%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (6.84%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 99.90x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (7.33x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dr. Agarwal's Health Care Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Dr. Agarwal's Health Care Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H...Selected✓ AGARWALEYE • 544350 | 57.3/100 | ₹468.55₹469 | ₹14853.03₹14853.03 | 99.90Average 99.9 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 64.1/100 | ₹7890.00₹7890 | ₹113458.20₹113458.20 | 54.29Average 54.3 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 55.5/100 | ₹846.00₹846 | ₹82336.10₹82336.10 | 56.44Average 56.4 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 50.6/100 | ₹736.50₹737 | ₹55602.80₹55602.80 | 53.06Average 53.1 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 65.7/100 | ₹1719.40₹1719 | ₹35137.83₹35137.83 | 42.79Average 42.8 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | 155.30%Excellent 155.30% Excellent | 25.05%Excellent 25.05% Excellent | 0.22% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 49.5/100 | ₹674.35₹674 | ₹34940.10₹34940.10 | 109.12Average 109.1 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 57.9/100 | ₹1240.00₹1240 | ₹33327.48₹33327.48 | 59.90Average 59.9 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
27.7/100 | ₹685.60₹686 | ₹28795.20₹28795.20 | 134.43Average 134.4 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 73/100 | ₹1248.90₹1249 | ₹12684.58₹12684.58 | 44.43Average 44.4 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | 44.04%Excellent 44.04% Excellent | 21.24%Excellent 21.24% Excellent | 0.23% |
Yatharth Hospital & Trauma Care Services LimitedYatharth Hospit... YATHARTH • 543950 | 66.1/100 | ₹992.10₹992 | ₹9559.28₹9559.28 | 52.77Average 52.8 Average | 9.98%Poor 9.98% Poor | 12.29%Average 12.29% Average | 0.14Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
50.9/100 | ₹588.20₹588 | ₹8781.83₹8781.83 | 379.48Average 379.5 Average | 1.22%Poor 1.22% Poor | 7.43%Poor 7.43% Poor | 0.68Good 0.7 Good | 17.65%Excellent 17.65% Excellent | 20.22%Excellent 20.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price113458.20 Cr
- Max Healthcare Institute Limited share price82336.10 Cr
- Fortis Healthcare Limited share price55602.80 Cr
- Narayana Hrudayalaya Ltd. share price35137.83 Cr
- Aster DM Quality Care Limited share price34940.10 Cr
Dr. Agarwal's Health Care Limited PE Ratio History
Historical price-to-earnings ratio for AGARWALEYE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.73 | ₹508.35 | 696.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Dr. Agarwal's Health Care Limited Dividend History
Annual cash dividends paid by AGARWALEYE — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.79 Cr |
| FY 2024 | ₹0.77 Cr |
| FY 2023 | ₹0.43 Cr |
| FY 2022 | ₹0.01 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Dr. Agarwal's Health Care Limited Quarterly Performance
Latest quarterly metrics for AGARWALEYE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
25.97%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
50.52%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
34.58%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
34.42%
Compounded annual net profit growth over 5 years
Dr. Agarwal's Health Care Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AGARWALEYE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Dr. Agarwal's Health Care Limited Financial Statements
Annual income statement, balance sheet and cash flow for Dr. Agarwal's Health Care Limited (AGARWALEYE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Dr. Agarwal's Health Care Limited
About AGARWALEYE (Dr. Agarwal's Health Care Limited)
Dr. Agarwal's Health Care Ltd is a network of advanced eye hospitals dedicated to preserving and restoring the precious gift of sight. Within the walls of their meticulously design...ed facilities, patients discover a sanctuary of healing, where cutting-edge technology meets compassionate care. Each hospital is a testament to Dr. Agarwal's commitment to innovation, equipped with state-of-the-art diagnostic tools and surgical suites designed to optimize patient comfort and clinical outcomes. The atmosphere is carefully cultivated to alleviate anxiety, fostering a sense of trust and confidence as patients embark on their journey to improved vision. From the moment one steps through the doors, the dedication to excellence is palpable, a reflection of the institution's legacy of pioneering ophthalmic advancements. At the heart of Dr. Agarwal's Health Care Ltd lies a team of highly skilled and specialized ophthalmologists, surgeons, and support staff. These dedicated professionals represent a collective wealth of experience, united by a shared passion for delivering exceptional patient care. They are not merely practitioners of medicine, but also empathetic listeners, taking the time to understand each patient's unique needs and concerns. This personalized approach extends beyond the clinical aspects, encompassing emotional support and clear communication throughout the entire treatment process. The surgeons possess expertise in an array of advanced procedures, from intricate corneal reconstructions to delicate retinal repairs, providing patients with access to the most comprehensive and sophisticated eye care available. Dr. Agarwal's Health Care Ltd stands as a beacon of hope for individuals seeking to overcome vision impairment and enhance their quality of life. Their commitment to pushing the boundaries of ophthalmic knowledge is evident in their ongoing research initiatives and clinical trials, driving innovation and shaping the future of eye care. Beyond the immediate treatment of eye conditions, Dr. Agarwal's prioritizes patient education and preventative care, empowering individuals to take proactive steps towards maintaining optimal eye health. They aim to provide solutions tailored to improve vision for better life experience. This holistic approach underscores Dr. Agarwal's Health Care Ltd's dedication to not just treating symptoms, but fostering a lifelong commitment to clear and healthy vision.
Company Details
Key Leadership
AGARWALEYE Share Price: Frequently Asked Questions
What is the current share price of Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited (AGARWALEYE) trades at ₹468.55 on NSE and BSE. Market cap ₹14.85K (Cr). Educational data only.
What is the P/E ratio of Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited has a P/E of 99.90x vs industry average 48.79x.
What is the Bull Run score for Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited has a Bull Run score of 57.3/100 based on 25+ financial parameters.
Does Dr. Agarwal's Health Care Limited pay dividends?
Dr. Agarwal's Health Care Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited has ROE of 6.84%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited has debt-to-equity of 0.08.
Is Dr. Agarwal's Health Care Limited a good investment?
Bull Run gives Dr. Agarwal's Health Care Limited a score of 57.3/100. This is not investment advice — consult a SEBI-registered advisor.